In 90% of PAP cases, autoantibodies that neutralise granulocyte macrophage-colony stimulating factor (GM-CSF) impair alveolar macrophage maturation, consequently hindering their ability to clear surfactant [55]. The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.